MetaVia Inc. (MTVA): Net Income
-$12.97M
Year ended 2025-12-31
-$14.45M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$12.97M | n/m | 2026-03-26, From 2025-01-01 |
| 2024-12-31 | -$27.59M | n/m | 2026-03-26, From 2024-01-01 |
| 2023-12-31 | -$12.47M | n/m | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | -$13.97M | n/m | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | -$15.28M | n/m | 2023-03-30, From 2021-01-01 |
| 2020-12-31 | -$29.68M | n/m | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | -$21.31M | n/m | 2021-04-15, From 2019-01-01 |
| 2018-12-31 | -$15.53M | n/c | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$33.41M | n/m | 2019-03-18, From 2017-01-01 |
| 2016-12-31 | -$14.59M | n/m | 2019-03-18, From 2016-01-01 |
| 2015-12-31 | -$9.03M | n/m | 2018-03-20, From 2015-01-01 |
| 2014-12-31 | -$320.0K | n/a | 2017-03-21, From 2014-01-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| MetaVia Inc. (MTVA) | 2025-12-31 | -$12.97M | n/m |
| Mira Pharmaceuticals, Inc. (MIRA) | 2025-12-31 | -$10.44M | n/m |
| Decoy Therapeutics Inc. (DCOY) | 2025-12-31 | -$12.52M | n/m |
| Lantern Pharma Inc. (LTRN) | 2025-12-31 | -$17.12M | n/m |
| NewcelX Ltd. (NCEL) | 2025-12-31 | -$8.30M | n/m |
| Curanex Pharmaceuticals Inc (CURX) | 2025-12-31 | -$4.23M | n/m |
| Revelation Biosciences, Inc. (REVB) | 2025-12-31 | -$8.91M | n/m |
| Traws Pharma, Inc. (TRAW) | 2025-12-31 | $9.17M | n/m |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | 2025-12-31 | -$11.72M | n/m |
Compare MTVA, MIRA, DCOY, LTRN side by side · Screen every company in Pharmaceutical Preparations ↗